title: [New developments in hypericum extracts: data on efficacy and interactions].
abstract: The recent clinical studies on hypericum extract support the present indications for its use in mild to moderate depression and depressive episodes. The effectiveness is superior to placebo and comparable with synthetic antidepressive drugs. The rate of unwanted events is explicitly lower and their severity in general only mild. A further indication for hypericum could be somatoform disorders, but further clinical studies are recommended. The main compound responsible for interactions is presumably hyperforin, but further ingredients could contribute according to the specific composition of the particular extract.
authors: Klinik und Poliklinik für Innere Medizin, Lehrstuhl für Naturheilkunde, Rostock, Germany. karin.kraft@med.uni-rostock.de
authors: Karin
authors: K
authors: Kraft
mesh_terms: D000293:Adolescent; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D001643:Bridged Bicyclo Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D015283:Citalopram / Q000008:administration & dosage / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D020902:Hypericum; D008297:Male; D010696:Phloroglucinol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D008517:Phytotherapy / Q000009:adverse effects; D010919:Placebos; D010936:Plant Extracts / Q000627:therapeutic use; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013001:Somatoform Disorders / Q000188:drug therapy; D013729:Terpenes / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D001643:Bridged Bicyclo Compounds; D015283:Citalopram; D005473:Fluoxetine; D010696:Phloroglucinol; D010919:Placebos; D010936:Plant Extracts; D017367:Selective Serotonin Reuptake Inhibitors; D013729:Terpenes; C001654:hyperforin
references: Pharmacopsychiatry. 2006 Mar;39(2):66-75
references: 16555167
references: Psychosom Med. 2004 Jul-Aug;66(4):538-47
references: 15272100
references: Br J Dermatol. 2005 Dec;153(6):1187-91
references: 16307656
references: Clin Pharmacokinet. 2006;45(5):449-68
references: 16640452
references: BMC Med. 2006 Jun 23;4:14
references: 16796730
references: Phytomedicine. 2006 Feb;13(3):199-204
references: 16428030
references: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448
references: 15846605
references: Eur J Clin Pharmacol. 2006 Mar;62(3):225-33
references: 16477470
references: J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):197-206
references: 16553540
references: Oncologist. 2006 Jul-Aug;11(7):742-52
references: 16880233
references: BMJ. 2004 Jul 3;329(7456):27-30
references: 15231618
references: Arzneimittelforschung. 2006;56(3):212-21
references: 16618014
references: Altern Med Rev. 2005 Mar;10(1):5-13
references: 15771558
references: Eur Arch Psychiatry Clin Neurosci. 2005 Feb;255(1):40-7
references: 15538592
references: J Clin Psychopharmacol. 2005 Feb;25(1):51-8
references: 15643100
references: Int Clin Psychopharmacol. 2005 Nov;20(6):299-304
references: 16192837
references: Pharmacopsychiatry. 2005 Mar;38(2):78-86
references: 15744631
references: Contraception. 2005 Jun;71(6):402-8
references: 15914127
references: J Clin Psychopharmacol. 2005 Oct;25(5):441-7
references: 16160619
references: J Child Adolesc Psychopharmacol. 2005 Apr;15(2):293-301
references: 15910213
references: BMJ. 2005 Mar 5;330(7490):503
references: 15708844
references: Phytomedicine. 2006 Mar;13(4):215-21
references: 16423519
references: Pharmacopsychiatry. 2005 Sep;38(5):194-200
references: 16189745
references: J Clin Psychiatry. 2006 Feb;67(2):305-9
references: 16566628
references: Can J Clin Pharmacol. 2006 Fall;13(3):e268-76
references: 17085775
references: Br J Clin Pharmacol. 2006 Nov;62(5):512-26
references: 17010103
references: J Pharmacol Sci. 2006 Sep;102(1):47-54
references: 16936454